11-94459412-T-C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_005591.4(MRE11):c.1496A>G(p.Glu499Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000274 in 1,461,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005591.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRE11 | NM_005591.4 | c.1496A>G | p.Glu499Gly | missense_variant | Exon 13 of 20 | ENST00000323929.8 | NP_005582.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRE11 | ENST00000323929.8 | c.1496A>G | p.Glu499Gly | missense_variant | Exon 13 of 20 | 1 | NM_005591.4 | ENSP00000325863.4 | ||
MRE11 | ENST00000323977.7 | c.1496A>G | p.Glu499Gly | missense_variant | Exon 13 of 19 | 1 | ENSP00000326094.3 | |||
MRE11 | ENST00000407439.7 | c.1505A>G | p.Glu502Gly | missense_variant | Exon 13 of 20 | 2 | ENSP00000385614.3 | |||
MRE11 | ENST00000393241.8 | c.1496A>G | p.Glu499Gly | missense_variant | Exon 13 of 20 | 5 | ENSP00000376933.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251358Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135866
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461584Hom.: 0 Cov.: 31 AF XY: 0.0000371 AC XY: 27AN XY: 727108
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ataxia-telangiectasia-like disorder 1 Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.E499G variant (also known as c.1496A>G), located in coding exon 12 of the MRE11A gene, results from an A to G substitution at nucleotide position 1496. The glutamic acid at codon 499 is replaced by glycine, an amino acid with similar properties. This alteration was reported in individual from a cohort of 684 HBOC families undergoing multi-gene testing (Li J et al. J. Med. Genet. 2016 Jan;53:34-42). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Ataxia-telangiectasia-like disorder Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 499 of the MRE11 protein (p.Glu499Gly). This variant is present in population databases (rs774145193, gnomAD 0.03%). This missense change has been observed in individual(s) with breast and/or ovarian cancer (PMID: 26534844). ClinVar contains an entry for this variant (Variation ID: 229851). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at